|
1
|
Kular J, Tickner J, Chim SM and Xu J: An
overview of the regulation of bone remodelling at the cellular
level. Clin Biochem. 45:863–873. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ono T, Hayashi M, Sasaki F and Nakashima
T: RANKL biology: Bone metabolism, the immune system, and beyond.
Inflamm Regen. 40(2)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jilka RL, Hangoc G, Girasole G, Passeri G,
Williams DC, Abrams JS, Boyce B, Broxmeyer H and Manolagas SC:
Increased osteoclast development after estrogen loss: Mediation by
interleukin-6. Science. 257:88–91. 1992.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Taguchi Y, Yamamoto M, Yamate T, Lin SC,
Mocharla H, DeTogni P, Nakayama N, Boyce BF, Abe E and Manolagas
SC: Interleukin-6-type cytokines stimulate mesenchymal progenitor
differentiation toward the osteoblastic lineage. Proc Assoc Am
Physicians. 110:559–574. 1998.PubMed/NCBI
|
|
5
|
Kaneshiro S, Ebina K, Shi K, Higuchi C,
Hirao M, Okamoto M, Koizumi K, Morimoto T, Yoshikawa H and
Hashimoto J: IL-6 negatively regulates osteoblast differentiation
through the SHP2/MEK2 and SHP2/Akt2 pathways in vitro. J
Bone Miner Metab. 32:378–392. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hikiji H, Takato T, Shimizu T and Ishii S:
The roles of prostanoids, leukotrienes, and platelet-activating
factor in bone metabolism and disease. Prog Lipid Res. 47:107–392.
2008.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Agas D, Marchetti L, Hurley MM and
Sabbieti MG: Prostaglandin F2α: A bone remodeling mediator. J Cell
Physiol. 228:25–29. 2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tokuda H, Kozawa O, Harada A and Uematsu
T: p42/p44 mitogen-activated protein kinase activation is involved
in prostaglandin F2α-induced interleukin-6 synthesis in
osteoblasts. Cell Signal. 11:325–330. 1999.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Minamitani C, Otsuka T, Takai S,
Matsushima-Nishiwaki R, Adachi S, Hanai Y, Mizutani J, Tokuda H and
Kozawa O: Involvement of Rho-kinase in prostaglandin F2α-stimulated
interleukin-6 synthesis via p38 mitogen-activated protein kinase in
osteoblasts. Mol Cell Endocrinol. 291:27–32. 2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kuroyanagi G, Tokuda H,
Matsushima-Nishiwaki R, Kondo A, Mizutani J, Kozawa O and Otsuka T:
Resveratrol suppresses prostaglandin F2α-induced osteoprotegerin
synthesis in osteoblasts: Inhibition of the MAP kinase signaling.
Arch Biochem Biophys. 542:39–45. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Campbell AP and Smrcka AV: Targeting G
protein-coupled receptor signalling by blocking G proteins. Nat Rev
Drug Discov. 17:789–803. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Casey LM, Pistner AR, Belmonte SL,
Migdalovich D, Stolpnik O, Nwakanma FE, Vorobiof G, Dunaevsky O,
Matavel A, Lopes CM, et al: Small molecule disruption of G beta
gamma signaling inhibits the progression of heart failure. Circ
Res. 107:532–539. 2010.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lehmann DM, Seneviratne AM and Smrcka AV:
Small molecule disruption of G protein beta gamma subunit signaling
inhibits neutrophil chemotaxis and inflammation. Mol Pharmacol.
73:410–418. 2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sudo H, Kodama HA, Amagai Y, Yamamoto S
and Kasai S: In vitro differentiation and calcification in a
new clonal osteogenic cell line derived from newborn mouse
calvaria. J Cell Biol. 96:191–198. 1983.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kozawa O, Suzuki A, Tokuda H and Uematsu
T: Prostaglandin F2α stimulates interleukin-6 synthesis via
activation of PKC in osteoblast-like cells. Am J Physiol.
272:E208–E211. 1997.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Simpson DA, Feeney S, Boyle C and Stitt
AW: Retinal VEGF mRNA measured by SYBR green I fluorescence: A
versatile approach to quantitative PCR. Mol Vis. 6:178–183.
2000.PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Laemmli UK: Cleavage of structural
proteins during the assembly of the head of bacteriophage T4.
Nature. 227:680–685. 1970.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Hurowitz EH, Melnyk JM, Chen YJ,
Kouros-Mehr H, Simon MI and Shizuya H: Genomic characterization of
the human heterotrimeric G protein alpha, beta, and gamma subunit
genes. DNA Res. 7:111–120. 2000.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Koch WJ, Hawes BE, Inglese J, Luttrell LM
and Lefkowitz RJ: Cellular expression of the carboxyl terminus of a
G protein-coupled receptor kinase attenuates G beta gamma-mediated
signaling. J Biol Chem. 269:6193–6197. 1994.PubMed/NCBI
|
|
21
|
Lv X, Gao K, Nie J, Zhang X, Zhang S, Ren
Y, Sun X, Li Q, Huang J, Liu L, et al: Structures of human
prostaglandin F2α receptor reveal the
mechanism of ligand and G protein selectivity. Nat Commun.
14(8136)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Franchimont N, Wertz S and Malaise M:
Interleukin-6: An osteotropic factor influencing bone formation?
Bone. 37:601–606. 2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kuroyanagi G, Hioki T, Tachi J,
Matsushima-Nishiwaki R, Iida H, Kozawa O and Tokuda H: Oncostatin M
stimulates prostaglandin D2-induced osteoprotegerin and
interleukin-6 synthesis in osteoblasts. Prostaglandins Leukot
Essent Fatty Acids. 192(102575)2023.PubMed/NCBI View Article : Google Scholar
|
